China-based medical supplies platform developer LinkedCare has received at least $70m in series D funding from investors including cosmetic surgery services platform So-Young and financial services technology provider Sheng Ye Capital.
Investment management firm Investcorp led the series D round while Jinding Capital, Matrix Partners China and Lightspeed China Partners also took part.
The company did not confirm the size of its latest round but said it has raised a total of over $100m across its series D round and a $30.6m series C2 round in December 2020 led by Lightspeed China Partners with participation from So-Young and Matrix Partners China.
LinkedCare has developed cloud-based supply chain management software for the dental and cosmetic surgery sectors, and provides its services to more than 30,000 dental and cosmetic surgery clinics in China.
The company raised $14.8m in an April 2019 series C1 round backed by insurer Taikang Life’s subsidiary Taikang Asset Management and Everest Venture Capital.
Local services portal Meituan Dianping supplied an undisclosed amount of series B-plus funding the previous year. LinkedCare had previously picked up $15.1m in a 2017 series B round that included Fosun Pharma, the pharmaceuticals division of diversified conglomerate Fosun.
The series B came after LinkedCare disclosed $10m of funding raised in 2016 across a series A round led by healthcare community platform DXY and a series A-plus round led by an unspecified subsidiary of Fosun. It had secured an undisclosed amount from Matrix Partners China in 2015.